Ocular Therapeutix Aktie
WKN DE: A1180P / ISIN: US67576A1007
|
04.11.2025 14:08:19
|
Ocular Therapeutix Inc. Q3 Loss Increases, Misses Estimates
(RTTNews) - Ocular Therapeutix Inc. (OCUL) revealed Loss for its third quarter that increased from last year and missed the Street estimates.
The company's earnings came in at -$69.42 million, or -$0.38 per share. This compares with -$36.49 million, or -$0.22 per share, last year.
Analysts on average had expected the company to earn -$0.35 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 5.8% to $14.54 million from $15.43 million last year.
Ocular Therapeutix Inc. earnings at a glance (GAAP) :
-Earnings: -$69.42 Mln. vs. -$36.49 Mln. last year. -EPS: -$0.38 vs. -$0.22 last year. -Revenue: $14.54 Mln vs. $15.43 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Ocular Therapeutix Incmehr Nachrichten
|
03.11.25 |
Ausblick: Ocular Therapeutix vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
|
04.08.25 |
Ausblick: Ocular Therapeutix mit Zahlen zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Ocular Therapeutix Incmehr Analysen
Aktien in diesem Artikel
| Ocular Therapeutix Inc | 9,19 | -1,31% |
|